1. Home
  2. EOLS vs YORW Comparison

EOLS vs YORW Comparison

Compare EOLS & YORW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EOLS
  • YORW
  • Stock Information
  • Founded
  • EOLS 2012
  • YORW 1816
  • Country
  • EOLS United States
  • YORW United States
  • Employees
  • EOLS N/A
  • YORW N/A
  • Industry
  • EOLS Biotechnology: Pharmaceutical Preparations
  • YORW Water Supply
  • Sector
  • EOLS Health Care
  • YORW Utilities
  • Exchange
  • EOLS Nasdaq
  • YORW Nasdaq
  • Market Cap
  • EOLS 589.3M
  • YORW 472.3M
  • IPO Year
  • EOLS 2018
  • YORW N/A
  • Fundamental
  • Price
  • EOLS $9.53
  • YORW $30.57
  • Analyst Decision
  • EOLS Strong Buy
  • YORW
  • Analyst Count
  • EOLS 5
  • YORW 0
  • Target Price
  • EOLS $23.75
  • YORW N/A
  • AVG Volume (30 Days)
  • EOLS 889.3K
  • YORW 98.3K
  • Earning Date
  • EOLS 08-05-2025
  • YORW 08-05-2025
  • Dividend Yield
  • EOLS N/A
  • YORW 2.87%
  • EPS Growth
  • EOLS N/A
  • YORW N/A
  • EPS
  • EOLS N/A
  • YORW 1.37
  • Revenue
  • EOLS $275,463,000.00
  • YORW $75,787,000.00
  • Revenue This Year
  • EOLS $33.42
  • YORW $7.50
  • Revenue Next Year
  • EOLS $33.18
  • YORW $6.33
  • P/E Ratio
  • EOLS N/A
  • YORW $22.36
  • Revenue Growth
  • EOLS 25.38
  • YORW 3.45
  • 52 Week Low
  • EOLS $8.67
  • YORW $29.86
  • 52 Week High
  • EOLS $17.82
  • YORW $41.96
  • Technical
  • Relative Strength Index (RSI)
  • EOLS 51.00
  • YORW 37.62
  • Support Level
  • EOLS $9.12
  • YORW $31.00
  • Resistance Level
  • EOLS $10.20
  • YORW $32.00
  • Average True Range (ATR)
  • EOLS 0.40
  • YORW 0.66
  • MACD
  • EOLS 0.05
  • YORW -0.07
  • Stochastic Oscillator
  • EOLS 44.17
  • YORW 5.02

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

About YORW York Water Company (The)

The York Water Co is an investor-owned water utility company in the United States. The primary business of the company is to impound, purify to meet or exceed safe drinking water standards and distribute water. It also owns and operates three wastewater collection systems and eleven wastewater collection and treatment systems. The company operates within its franchised territory, which covers more than 57 municipalities within four counties in south-central Pennsylvania.

Share on Social Networks: